Francis M. Ndungu
Kenyan immunologist at KEMRI-Wellcome, Kilifi, and KI affiliate. I study why malaria immunity fades, to help build better vaccines, and love training the next generation of scientists.
About me
I'm a Kenyan immunologist, and I've spent my career asking one question: how does our immune system learn to fight malaria, and how can we help it do better?
I'm based at the KEMRI-Wellcome Trust Research Programme in Kilifi, a small town on Kenya's Indian Ocean coast and one of the best places in the world to study malaria. I lead a research group here and have chaired the Bioscience Department.
I trained as a science teacher at Kenyatta University in Nairobi, then took a detour into parasites with an MSc in Medical Parasitology. That detour became a career. I moved to London for a PhD and postdoctoral work at the MRC National Institute for Medical Research, then came home to Kilifi in 2008 to study immunity where malaria actually happens.
Today I also collaborate with Karolinska Institutet (working with Anna Färnert's group since 2013), the University of Oxford, Pwani University and the University of Glasgow. Along the way I've published more than 85 research papers and won funding from CEPI, the NIH, EDCTP and the UK Medical Research Council.
Away from the lab, I co-founded the Tunaweza Education Trust ("tunaweza" means "we can" in Swahili). It helps bright children from poor families go to secondary school.
Research
Why do some people stay healthy when malaria strikes again, while others fall ill? That's the puzzle my group works on. Our immune system remembers infections it has met before, but with malaria that memory is often patchy and fades quickly. We want to understand why, and use that knowledge to design better vaccines. We work mainly on malaria, and since 2020 also on COVID-19. Our research is built on two special resources in Kilifi: - Groups of local children whose health and immunity we have followed for many years. - Carefully controlled studies in which adult volunteers, who have had malaria before, receive a small dose of the parasite under close medical care. This lets us see, in real time, which immune responses actually protect. Our main questions: - Memory: How long do antibodies and "memory" immune cells last, and what makes them wake up and respond when they are needed? - Brakes on immunity: Repeated infections can tire out the immune system or switch it into "brake" mode. How does this let the parasite slip through? - Vaccines: What does a protective immune response look like after malaria vaccines (RTS, S and R21) and COVID-19 vaccines? - The bigger picture: How do worm infections, low iron and HIV change the way people fight malaria? Together with Karolinska Institutet, we compare people in Kenya, who meet malaria again and again, with Swedish travellers and migrants, who may meet it only once. Setting the two side by side shows us what repeated infection does to immune memory, and what a single infection leaves behind.
Teaching
I started out as a trained science teacher, and I've never really stopped teaching. In Kenya, I teach immunology of infectious diseases at Pwani University in Kilifi. Further afield, I have taught on the IDA immunology course in Cape Town, South Africa, sharing what we've learned about immune memory in malaria with young scientists from across the continent. I'm especially proud to have co-founded AfriBOP, a hands-on training course for early-career African scientists studying parasites and the immune system, where I also teach. I've also helped run career-development workshops for emerging African science leaders. Much of my teaching happens in the lab. I have supervised or co-supervised 8 PhD students, 13 MSc students, research interns and 3 postdoctoral fellows. They have come through the Open University, Oxford, Glasgow, Freie Universität Berlin and Karolinska Institutet, where I have co-supervised four PhD students with Anna Färnert and hosted them in Kilifi for their fieldwork. Many of my former students now lead research of their own in Kenya, the UK and beyond. For eight years (2014–2022) I coordinated research degrees at KEMRI-Wellcome, helping make sure our PhD students got training that met international standards. I'd love to contribute to teaching at KI in immunology, infection biology and global health.
Articles
- Journal article: LANCET MICROBE. 2026;7(9):101375Kimenyi KM; Morter R; Nyabundi D; Orindi B; Mwikali K; Mwai K; Kamau A; Mwacharo J; Musyoki J; Kapulu M; Abdi AI; Hill A; Ewer K; Bejon P; Ndungu FM
- Journal article: VACCINE. 2026;88:128837Safari MS; Gicheru ET; Mburu MW; Makori TO; Nyawa O; Odoyo SO; Shee F; Ndungu F; Foley DJ; Nyagwange J; Chege T; Sande CJ
- Journal article: NPJ VACCINES. 2026Agnandji ST; Ahmed R; Anderson J; Auderset F; Bejon P; Borgianni L; Brosnahan J; Ciabattini A; Engler O; Haks MC; Heppner DG; Gerlini A; Huttner A; Kremsner PG; Medaglini D; Monath TP; Ndungu FM; Njuguna P; Pejoski D; Page M; Pozzi G; Santoro F; Siegrist C-A; Ciabattini A; Dubey S; Eichberg MJ; Gonzalez-Dias P; Kabwende L; Nakaya H; Nakka SS; Persson J; Rothenberger S; van Veen S
- Journal article: ELIFE. 2026;14:RP107820Safari MS; Makori TO; Gicheru ET; Mburu MW; Nyawa OK; Shee FM; Nyagwange J; Kagucia EW; Ndungu FM; Kuria TC; Tuju JO; Sande CJ
- Article: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2026;16:1750881Miglar A; Amadi D; Grannas D; Widman L; Mwacharo J; Musyoki J; Kai O; Bejon P; Maccharia A; Williams TN; Farnert A; Asghar M; Ndungu FM
- Journal article: NATURE COMMUNICATIONS. 2026;17(1):6472Ogwang R; Nkumama IN; Mwai K; Odera D; Nyamako L; Fürle K; Rosenkranz M; Kimathi R; Njuguna P; Sim BKL; Hamaluba M; Frank R; CHMI-SIKA Study Team; Kapulu MC; Bejon P; Tuju J; Osier FHA
- Journal article: NATURE COMMUNICATIONS. 2026;17(1):7068Muriuki JM; Mentzer AJ; Band G; Chong AY; Macharia AW; Mogire RM; Abuga KM; Mitchell R; Gilchrist JJ; Webb EL; Ndungu FM; Raffield LM; Ekunwe L; Bentley AR; Sirima SB; Madhi SA; Hill AVS; Prentice AM; Bejon P; Hemani G; Smith GD; Sandhu MS; Elliott AM; Williams TN; Adeyemo A; Atkinson SH
- Article: BMC INFECTIOUS DISEASES. 2026;26(1):174Wanjiku P; Orindi B; Mwacharo J; Chemweno J; Karanja HK; Kronsteiner B; Kai O; Wright D; Ochola-Oyier LI; Sundling C; Dunachie S; Warimwe GM; Farnert A; Bejon P; Ndungu FM; Nduati EW
- Journal article: PLOS ONE. 2025;20(9):e0316967Wanjiku P; Orindi B; Kimotho J; Sayed S; Shah R; Saleh M; Mwacharo J; Maronga C; Olouch V; Karanu A; Shah J; Nneka Z; Ochola-Oyier LI; Abdi AI; Dunachie S; Bejon P; Nduati EW; Ndungu FM
- Journal article: EBIOMEDICINE. 2025;113:105600Abouyannis M; Nyambura YK; Ngome S; Riako D; Musyoki J; Muiruri C; Orindi B; Else L; Amara A; Dickinson L; Clare RH; Albulescu L-O; Westhorpe AP; Kool J; Adetifa I; Ndungu FM; Fitzgerald R; Khoo S; Lalloo DG; Casewell NR; Hamaluba M
- Journal article: JOURNAL OF INFECTION. 2024;89(4):106252Kinyua AW; Turner L; Kimingi HW; Mwai K; Mwikali K; Andisi C; Sim BKL; Bejon P; Kapulu MC; Kinyanjui SM; Lavstsen T; Abdi AI; CHMI-SIKA Study Team
- Journal article: LIFE SCIENCE ALLIANCE. 2024;7(8):e202301910Rosenkranz M; Nkumama IN; Ogwang R; Kraker S; Blickling M; Mwai K; Odera D; Tuju J; Fürle K; Frank R; Chepsat E; Kapulu MC; Study Team C-S; Osier FH
- Journal article: IMMUNITY. 2024;57(6):1215-1224.e6Nkumama IN; Ogwang R; Odera D; Musasia F; Mwai K; Nyamako L; Murungi L; Tuju J; Fürle K; Rosenkranz M; Kimathi R; Njuguna P; Hamaluba M; Kapulu MC; Frank R; CHMI-SIKA study team; Osier FHA
- Journal article: PLOS NEGLECTED TROPICAL DISEASES. 2024;18(6):e0012279Mugo RM; Rausch S; Musimbi ZD; Strube C; Raulf M-K; Landt O; Gichuki PM; Ebner F; Mwacharo J; Odiere MR; Ndungu FM; Njomo DW; Hartmann S
- Journal article: ISCIENCE. 2023;26(12):108574Vianello E; Persson J; Andersson B; van Veen S; Dias TL; Santoro F; Östensson M; Obudulu O; Agbajogu C; Torkzadeh S; VSV-EBOVAC; VSV-EBOPLUS Consortia; Nakaya HI; Medaglini D; Siegrist C-A; Ottenhoff THM; Harandi AM
- Journal article: CLINICAL MICROBIOLOGY AND INFECTION. 2023;29(12):1587-1594Huttner A; Agnandji ST; Engler O; Hooper JW; Kwilas S; Ricks K; Clements TL; Jonsdottir HR; Nakka SS; Rothenberger S; Kremsner P; Züst R; Medaglini D; Ottenhoff T; Harandi AM; Siegrist C-A; VEBCON; VSV-EBOVAC; VSV-EBOPLUS Consortia
- Journal article: ELIFE. 2023;12:e83874Kariuki SN; Macharia AW; Makale J; Nyamu W; Hoffman SL; Kapulu MC; Bejon P; Rayner JC; Williams TN; CHMI-SIKA Study Team
- Journal article: PLOS ONE. 2023;18(5):e0286117Mugo RMM; Orindi B; Shee FMM; Bellamy D; Mwacharo J; Ewer KJJ; Bejon P; Ndungu FMM
- Journal article: SCIENCE TRANSLATIONAL MEDICINE. 2023;15(682):eabn5993Odera DO; Tuju J; Mwai K; Nkumama IN; Fürle K; Chege T; Kimathi R; Diehl S; Musasia FK; Rosenkranz M; Njuguna P; Hamaluba M; Kapulu MC; Frank R; CHMI-SIKA Study Team; Osier FHA; Abdi AI; Chi PC; de Laurent Z; Jao I; Kamuya D; Kamuyu G; Makale J; Murungi L; Musyoki J; Muthui M; Mwacharo J; Kariuki S; Mwanga D; Mwongeli J; Ndungu F; Njue M; Nyangweso G; Kimani D; Ngoi JM; Musembi J; Ngoto O; Otieno E; Ooko M; Shangala J; Wambua J; Mohammed KS; Omuoyo D; Mosobo M; Kibinge N; Kinyanjui S; Bejon P; Lowe B; Marsh K; Marsh V; Abebe Y; Billingsley PF; Sim BKL; Hoffman SL; James ER; Richie TL; Audi A; Olewe F; Oloo J; Ongecha J; Ongas MO; Koskei N; Bull PC; Hodgson SH; Kivisi C; Imwong M; Murphy SC; Ogutu B; Tarning J; Winterberg M; Williams TN
- Journal article: WELLCOME OPEN RESEARCH. 2023;8:450Sang S; Datoo MS; Otieno E; Muiruri C; Bellamy D; Gathuri E; Ngoto O; Musembi J; Provstgaard-Morys S; Stockdale L; Aboagye J; Woods D; Lawrie A; Roberts R; Keter K; Kimani D; Ndungu F; Kapulu M; Njau I; Orindi B; Ewer KJ; Hill AVS; Bejon P; Hamaluba M
- Show more
All other publications
- Preprint: BIORXIV. 2026Lim P; Jung N; Gabriela M; Krol J; Reaksudsan K; Naung M; Marapana D; Chan RWB; Nyabundi D; Mwacharo J; Kapulu M; Bejon P; Ndungu F; Barry A; Murugan R; Yang A; Cowman A; Scally S
- Preprint: SSRN ELECTRONIC JOURNAL. 2026Safari MS; Gicheru ET; Mburu MW; Makori TO; Nyawa O; Shee F; Ndungu FM; Foley DJ; Nyagwange J; Chege T; Sande C
- Preprint: RESEARCH SQUARE. 2025Muriuki J; Mentzer A; Band G; Chong A; Macharia A; Mogire R; Abuga K; Mitchell R; Gilchrist J; Webb E; Ndungu F; Raffield L; Ekunwe L; Bentley A; Sirima S; Madhi S; Hill A; Prentice A; Bejon P; Hemani G; Smith GD; Sandhu M; Elliott A; Williams T; Adeyemo A; Atkinson S
- Preprint: MEDRXIV. 2025;MEDRXIVMogire RM; Muriuki JM; Bayimenye RF; Mentzer AJ; Chong A; Gouveia MH; Bentley AR; Band G; King'ori P; Mitchell R; Webb EL; Sengupta D; Ekunwe L; Ndungu FM; Morovat A; Macharia AW; Cutland CL; Hemani G; Sirima SB; Ramsay M; Figueiredo CA; Prentice AM; Madhi SA; Raffield LM; Sandhu MS; Bejon P; Smith GD; Elliott AM; Williams TN; Rotimi C; Bourne CR; Burgett A; Adeyemo A; Atkinson SH
- Preprint: MEDRXIV. 2025Safari M; Makori T; Gicheru E; Mburu M; Nyawa O; Shee F; Nyagwange J; Kagucia E; Ndungu F; Chege T; Tuju J; Sande C
- Preprint: MEDRXIV. 2025Muriuki JM; Mentzer AJ; Band G; Chong AY; Macharia AW; Mogire RM; Abuga KM; Mitchell R; Gilchrist JJ; Webb EL; Ndungu FM; Raffield LM; Ekunwe L; Bentley AR; Sirima SB; Madhi SA; Hill AVS; Prentice AM; Bejon P; Hemani G; Smith GD; Sandhu MS; Elliott AM; Williams TN; Adeyemo A; Atkinson SH
- Preprint: MEDRXIV. 2025Wanjiku P; Orindi B; Mwacharo J; Chemweno J; Karanja H; Kronsteiner-Dobramysl B; Kai O; Wright D; Ochola-Oyier LI; Sundling C; Dunachie S; Warimwe G; Farnert A; Bejon P; Ndungu F; Nduati E
- Preprint: MEDRXIV. 2024Wanjiku P; Orindi B; Kimotho J; Sayed S; Shah R; Saleh M; Mwacharo J; Maronga C; Olouch V; Karanu A; Shah J; Nneka Z; Ochola-Oyier LI; Abdi AI; Dunachie S; Bejon P; Nduati E; Ndungu FM
- Preprint: WELLCOME OPEN RESEARCH. 2023Kimotho J; Sein Y; Sayed S; Shah R; Mwai K; Saleh M; Wanjiku P; Mwacharo J; Nyagwange J; Karanja H; Kutima B; Gitonga J; Mugo D; Karanu A; Moranga L; Oluoch V; Shah J; Mutiso J; Mburu A; Nneka Z; Betti P; Usyu Mutinda W; Issak Abdi A; Bejon P; Isabella Ochola-Oyier L; M.Warimwe G; Nduati E; M. Ndungu F
- Preprint: MEDRXIV. 2022Kimotho J; Sein Y; Sayed S; Shah R; Mwai K; Saleh M; Wanjiku P; Mwacharo J; Nyagwange J; Karanja H; Kutima B; Gitonga J; Mugo D; Karanu A; Moranga L; Oluoch V; Shah J; Mutiso J; Mburu A; Nneka Z; Betti P; Mutinda WU; Abdi AI; Bejon P; Ochola-Oyier LI; Warimwe GM; Nduati E; Ndungu FM
- Preprint: WELLCOME OPEN RESEARCH. 2022Valletta JJ; Addy JWG; Reid A; Ndungu F; Bediako Y; Mwacharo J; Mohammed KS; Musyoki J; Ngoi JM; Wambua J; Otieno E; Berriman M; Bejon P; Marsh K; Langhorne J; Newbold C; Recker M
- Preprint: MEDRXIV. 2021Mogire R; Muriuki JM; Morovat A; Mentzer A; Webb E; Kimita W; Ndungu F; Macharia A; Cutland C; Sirima S; Diarra A; Tiono A; Lule S; Madhi S; Prentice A; Bejon P; Pettifor J; Elliott A; Adeyemo A; Williams T; Atkinson S
- Preprint: BIORXIV. 2020Sutton H; Aye R; Idris A; Vistein R; Nduati E; Kai O; Mwacharo J; Li X; Gao X; Andrews D; Koutsakos M; Nguyen T; Nekrasov M; Milburn P; Ethala A; Berry A; Natasha KC; Chakravarty S; Sim KL; Wheatley A; Kent S; Hoffman S; Lyke K; Bejon P; Luciani F; Kedzierska K; Seder R; Ndungu F; Cockburn I
- Review: IMMUNOLOGICAL REVIEWS. 2020;293(1):57-69Perez-Mazliah D; Ndungu FM; Aye R; Langhorne J
- Preprint: SSRN ELECTRONIC JOURNAL. 2020Mogire RM; Muriuki JM; Mentzer AJ; Webb E; Kimita W; Macharia AW; Ndungu FM; Cutland C; Sirima S; Diarra A; Tiono AB; Lule SA; Morovat A; Madhi SA; Bejon P; Pettifor JM; Eliott A; Adeyemo A; Williams TN; Atkinson SH
- Preprint: SSRN ELECTRONIC JOURNAL. 2019Muriuki JM; Mentzer AJ; Webb E; Morovat A; Kimita W; Ndungu FM; Macharia AW; Crane RJ; Berkley JA; Lule SA; Cutland C; Sirima S; Diarra A; Tiono AB; Bejon P; Madhi SA; Hill AVS; Prentice AM; Suchdev PS; Elliott AM; Williams TN; Atkinson S
- Preprint: WELLCOME OPEN RES. 2019Ndungu F; Mwacharo J; Wambua J; Njuguna P; Marsh K; Drakeley C; Bejon P
- Conference publication: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2017;97(5):129REGULATORY T CELL-MEDIATED SUPPRESSION OF HUMAN IMMUNE RESPONSES TO INVESTIGATIONAL MALARIA VACCINESMorter RA; Ndungu FM; Hill AV; Bejon P; Ewer K
- Conference publication: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2013;18:141Ndungu F; Sonden K; Rono J; Illingworth J; Eriksson S; Arnert AF
- Book chapter: IMMUNITY TO PARASITIC INFECTION. 2012;p. 91-106Lamb TJ; Ndung'u FM
- Show more
Grants
- Medical Research Council1 February 2022 - 30 November 2026Plasmodium falciparum malaria causes an estimated 500 million cases per year and hundreds of thousands of deaths annually. Substantial morbidity and mortality occurs in Africa. An effective vaccine is needed, and vaccine development is essential to provide an effective sustainable and cost-effective control of disease. Rational vaccine development would be based on clearly described mechanisms that lead to clearance of parasites and the correlates of immunity. The current lead vaccine, based on the first falciparum gene ever cloned, delivers ~30% protection over 4 years. An understanding and identification of the underlying mechanisms that lead to naturally acquired immunity has the potential to inform rational vaccine design. We need to identify the antigenic targets for protective immune responsesand the threshold required and functional properties. The study of naturally acquired immunity has been conducted using observational field studies to date, based on surveillance of naturally exposed children. However, adults living in endemic areas acquire resistance to infection and/or disease with repeated exposure to malaria causing parasites. To understand how this immunity impacts infection, we recently conducted a deliberate infection study using parasite stages that are infective from the mosquito, sporozoites. Out of a total of 142 volunteers, 33 were observed to be malaria parasite free and remained uninfected throughout monitoring for infection in the study. These studies in non-endemic volunteers, with 100% developing infection, have recently been used to investigate pathophysiological mechanisms of disease utilising the stage of the parasite responsible for disease, blood stages i.e. deliberate infection with parasite infected red blood cells. We now propose to deliberately infect volunteers who we found to be previously malaria-free with parasite-infected red blood cells that directly results in the signs and symptoms associated with disease. We intend to evaluate pathophysiological mechanisms of disease and determine the contribution and mechanisms of immunity resulting from the disease stage of infection. We will adopt a biomarker and systems immunology approach to identify mechanisms associated with disease outcome including detailed characterisation of biomarkers of immune activation including endothelial activation and microvascular functiontyping of antibody specificities and function, analysis of cellular immunityand analysis of the metabolome. This study will define mechanisms associated with disease in the context of pre-existing immunity and help inform targets for the next generation blood-stage vaccines. Technical Summary Plasmodium falciparum malaria causes substantial morbidity and mortality in Africa. A high-efficacy vaccine is essential. The current lead malaria vaccine confers ~30% protection over 4 years and is based on the major antigen on the surface of pre-erythrocytic sporozoite parasite stages. An attractive strategy to build on this partial efficacy is a multi-stage vaccine including immunity against blood-stages of the parasites. However, there is no analogous single major antigen for blood stage parasites, and vaccines based on several different blood stage antigens have not been successful. Adults in endemic areas acquire immunity to blood-stage parasites after repeated malaria exposure. Identifying the underlying mechanisms of naturally acquired immunity has the potential to inform rational vaccine design e.g. antigen selection. We recently completed controlled human malaria infection (CHMI) studies in Kenyan adults using cryopreserved sporozoites (PfSPZ) and identified 33 out of 142 volunteers who remained uninfected by sensitive blood PCR for malaria parasites. The PCR negative volunteers are likely to have high levels of acquired immunity, and imply an excellent model for vaccine development. However the protection may have resulted either from immunity to pre-erythrocytic or to blood-stage parasites. The distinction is critical for further study and vaccine design. We now propose a blood-stage challenge experiment for these previously protected volunteers since this will bypass pre-erythrocytic stages to determine the contribution of blood-stage immunity and mechanisms. We aim to: (a) test whether a key component of malaria immunity is through an immune response to blood-stage infectionand (b) test whether individuals who are especially immune are able to control higher inoculums of parasitesand (c) define immunological mechanisms associated protection and/or disease pathogenesis to inform the development of the next generation of blood-stage malaria vaccines.
- Host immune responses to SARS-CoV-2: correlating kinetics with the natural history of infectionEuropean & Developing Countries Clinical Trials Partnership1 July 2020 - 31 December 2023
- Determining Correlates of Naturally Acquired Pre-Erythrocytic Immunity to Plasmodium falciparum Malaria in an Experimental Human Challenge ModelEuropean & Developing Countries Clinical Trials Partnership1 April 2019 - 30 September 2024
- Medical Research Council31 August 2017 - 30 August 2024
- Accelerating the development of next generation malaria vaccines through development of innovative trial designs in malaria-endemic areas.Wellcome Trust Ltd1 November 2015 - 30 April 2023
- Medical Research Council29 May 2014 - 28 February 2020
Employments
- Affiliated Scientist, Department of Medicine, Karolinska Institutet, 2020-
- Adjunct Lecturer, Pwani University, 2010-
- Group Leader, Malaria Immunology, Kenya Medical Research Institute - Wellcome Research Programme, 2008-
- Affiliated to Research, Department of Medicine, Karolinska Institutet, 2025-2028
Visiting research fellowships
- Honorary Visiting Research Fellow, University of Oxford, Honorary Visiting Research Fellow at the Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford., 2015
- Adjunct Lecturer, Pwani University, Adjunct Lecturer appointment., 2010
- Affiliated Research Scientist, Freie Universität Berlin
Editorial work
- Malaria Journal, Associate editor, 2026
- Frontiers in Immunology, Associate editor, 2022